In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen

scientific article published on 23 April 2016

In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5812/JJM.36638
P932PMC publication ID4977912
P698PubMed publication ID27540459

P50authorHamid BadaliQ40035132
Rasoul MohammadiQ41440314
Mojtaba DidehdarQ57331837
Tahereh ShokohiQ58980845
Mohammad Hossein AfsarianQ83737014
P2093author name stringNasrin Amirrajab
Nazanin Lotfi
P2860cites workCandida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicansQ24550731
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.Q30453032
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobiaQ30453797
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.Q33830384
Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcomeQ33935389
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.Q34372192
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.Q34936576
Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.Q35071660
Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillanceQ35487439
Multilocus sequence typing of Candida albicans isolates from a burn intensive care unit in IranQ35544090
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.Q35641405
Determination of antifungal susceptibility patterns among the clinical isolates of Candida speciesQ35646997
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrataQ35867789
Multidrug resistance in yeast CandidaQ35983675
Current treatment strategies for disseminated candidiasisQ36342385
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.Q36803960
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogrQ37036246
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.Q37374850
Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistanceQ37875198
Candida glabrata--unique features and challenges in the clinical management of invasive infectionsQ38553440
Antifungal susceptibility testing of Candida isolates from the Candida surveillance studyQ39901515
Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser.Q40237015
High Recovery Rate of Non-albicans Candida Species Isolated From Burn Patients With Candidemia in Iran.Q40902635
Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis.Q41578149
Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.Q42222261
The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methodsQ42222742
FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based SurveillanceQ42250085
Clinical significance of azole antifungal drug cross-resistance in Candida glabrataQ42408609
Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patientsQ42992243
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance programQ44801009
Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazoleQ46740583
Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patientQ46971624
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.Q47643534
Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents.Q51174529
P433issue5
P921main subjectCandida glabrataQ139137
emerging pathogenQ108429945
P304page(s)e36638
P577publication date2016-04-23
P1433published inJundishapur journal of microbiology JJMQ26841997
P1476titleIn Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen
P478volume9

Reverse relations

cites work (P2860)
Q51806793Antimicrobial Effect of Copper Oxide Nanoparticles on Some Oral Bacteria and Candida Species.
Q89912171In vitro activity of four triazole antifungal drugs against clinically common and uncommon yeast species
Q92650185Microsatellite Typing and Antifungal Susceptibility of Candida glabrata Strains Isolated From Patients With Candida Vaginitis

Search more.